REGNT1

REGENERON PHARMACEUTICALS, INC.

Financial Intelligence

Scored 11/1/2026

Buffett Quality

2.0/10

Lynch Category

Stalwart

Margin of Safety

—

Acquisition Risk

Not flagged

Owner Earnings

$5.0B

Recent Signals

20 found
insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 219 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 27 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 192 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 105 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 121 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 55 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 376 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 454 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 380 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 224 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 74 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 38 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 271 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 279 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 66 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 25 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 50 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 463 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 127 · filing_date: 2026-10-15

10/15/2026

50%

insider_transaction

REGENERON PHARMACEUTICALS, INC.

is_buy: false · shares: 211 · filing_date: 2026-10-15

10/15/2026

50%

Watch Reason

S&P 500 / major index component — seeded via EDGAR